AIRLINK 62.48 Increased By ▲ 2.05 (3.39%)
BOP 5.36 Increased By ▲ 0.01 (0.19%)
CNERGY 4.58 Decreased By ▼ -0.02 (-0.43%)
DFML 15.50 Increased By ▲ 0.66 (4.45%)
DGKC 66.40 Increased By ▲ 1.60 (2.47%)
FCCL 17.59 Increased By ▲ 0.73 (4.33%)
FFBL 27.70 Increased By ▲ 2.95 (11.92%)
FFL 9.27 Increased By ▲ 0.21 (2.32%)
GGL 10.06 Increased By ▲ 0.10 (1%)
HBL 105.70 Increased By ▲ 1.49 (1.43%)
HUBC 122.30 Increased By ▲ 4.78 (4.07%)
HUMNL 6.60 Increased By ▲ 0.06 (0.92%)
KEL 4.50 Decreased By ▼ -0.05 (-1.1%)
KOSM 4.48 Decreased By ▼ -0.09 (-1.97%)
MLCF 36.20 Increased By ▲ 0.79 (2.23%)
OGDC 122.92 Increased By ▲ 0.53 (0.43%)
PAEL 23.00 Increased By ▲ 1.09 (4.97%)
PIAA 29.34 Increased By ▲ 2.05 (7.51%)
PIBTL 5.80 Decreased By ▼ -0.14 (-2.36%)
PPL 107.50 Increased By ▲ 0.13 (0.12%)
PRL 27.25 Increased By ▲ 0.74 (2.79%)
PTC 18.07 Increased By ▲ 1.97 (12.24%)
SEARL 53.00 Decreased By ▼ -0.63 (-1.17%)
SNGP 63.21 Increased By ▲ 2.01 (3.28%)
SSGC 10.80 Increased By ▲ 0.05 (0.47%)
TELE 9.20 Increased By ▲ 0.71 (8.36%)
TPLP 11.44 Increased By ▲ 0.86 (8.13%)
TRG 70.86 Increased By ▲ 0.95 (1.36%)
UNITY 23.62 Increased By ▲ 0.11 (0.47%)
WTL 1.28 No Change ▼ 0.00 (0%)
BR100 6,944 Increased By 65.8 (0.96%)
BR30 22,827 Increased By 258.6 (1.15%)
KSE100 67,142 Increased By 594.3 (0.89%)
KSE30 22,090 Increased By 175.1 (0.8%)
World

Brazilian clinics to buy India's COVAXIN vaccine pending approval

  • Private sector talks to acquire Bharat's COVAXIN vaccine would not interfere with the Brazilian government's efforts to acquire vaccines for the public sector.
  • Bharat Biotech said on Tuesday that it had signed an agreement with a Brazil-based pharmaceutical seller, Precisa Medicamentos, to supply the vaccine even though it has yet to be approved.
Published January 13, 2021

SAO PAULO: Brazil's private sector vaccine clinics will be able to give customers a COVID-19 shot developed by India's Bharat Biotech once Brazil's federal health regulator has approved the drug, the head of the Brazilian Association of Vaccine Clinics (ABCVAC) said on Wednesday.

Speaking after a trip to visit Bharat Biotech executives in India, ABCVAC President Geraldo Barbosa said that private sector talks to acquire Bharat's COVAXIN vaccine would not interfere with the Brazilian government's efforts to acquire vaccines for the public sector.

Barbosa said that private clinics would only be able to buy the vaccine once health regulator Anvisa has signed off on the drug. He did not say whether a deal with Bharat had been signed, nor did he provide specific numbers on the size of any order.

Brazil's President Jair Bolsonaro is under mounting pressure because of the slow pace of the country's vaccine rollout. Inoculations have yet to begin in Latin America's largest country and Anvisa has yet to approve any vaccine for use.

Bharat Biotech said on Tuesday that it had signed an agreement with a Brazil-based pharmaceutical seller, Precisa Medicamentos, to supply the vaccine even though it has yet to be approved.

Comments

Comments are closed.